CPRX
Catalyst Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $2.61B | Price | $21.27 |
| Volume | 980.14K | Change | +1.43% |
| P/E Ratio | 16.0 | Open | $20.87 |
| Revenue | $491.7M | Prev Close | $20.97 |
| Net Income | $163.9M | 52W Range | $19.05 - $26.58 |
| Div Yield | N/A | Target | $34.00 |
| Overall | 74 | Value | 80 |
| Quality | 68 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyCatalyst Pharmaceuticals Inc. (CPRX) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $21.27 with a market capitalization of $2.61 billion. The stock is in the lower portion of its trading range, demonstrating solid quality metrics with a MarketXLS quality score of 68.
Today's trading session shows CPRX with a volume of 980K shares. The stock opened down 0.48% from yesterday's close of $20.97. Current analyst estimates project earnings of $2.19 per share for this year, with next year targeting $2.3.
CPRX demonstrates strong technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including BMRN, SRPT, JNJ, ACOR, PFE.
Key investment considerations for CPRX include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 59.8%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 08:36 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CPRX | $21.27 | +1.4% | 980.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Catalyst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW